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ABSTRACT 
Cell-free protein production is a new technology that offers many advantages over conventional 
cell-based expression techniques, though low yields (in the range of µg/ml) have been a major 
drawback.  With the advent of the p-gel system, a DNA hydrogel consisting of genes as part of 
the gel scaffolding, yields in the mg/ml range have been demonstrated.  As p-gel expression 
relies on exogenous transcriptional and translational enzymes, cloning these proteins into the p-
gel system would increase its autonomy.  Here, we attempt to clone T7 RNA polymerase into a 
vector compatible with the p-gel system.  Primers were designed to amplify T7 RNA polymerase 
from E. coli strain BL21 (DE3) as well as attach NcoI and SmaI restriction enzyme sites via 
PCR.  The amplicon was digested and ligated with Roche’s pIVEX2.4d, a plasmid that supports 
cell-free protein expression in E. coli  lysate with bacteriophage T7 RNA polymerase.  The 
plasmid was then used to transform chemically competent E. coli cells.  Colonies carrying the 
plasmid of interest were selected for via colony PCR and submitted for sequencing.  
Unfortunately, our samples displayed an abundance of mutations that would likely affect T7 
RNA polymerase’s activity.  Nonetheless, with additional work, the plasmid samples produced 
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The P-gel System 
  Though well established, cell-based  protein expression leaves much to be desired.  
Through evolution, wild-type cells have optimized the production of their native proteins, 
transforming metabolites into functional products with stunning efficiency.  In coaxing an 
organism to produce a foreign protein, however, biologists are attempting to fit a square peg into 
a round hole.  Often, proteins require significant modification to achieve even modest expression 
levels.  In order to promote acceptable yields, a precise extracellular environment must be 
maintained and extensive purification is required to separate a protein of interest from native 
proteins and structures, resulting in a labor intensive, expensive, and time consuming process.  
Furthermore,  cellular protein production is limited in its scope of expression.  Membrane 
proteins, toxic proteins, proteins that undergo rapid proteolysis, and proteins containing 
unnatural amino acids are all nearly impossible to express using a cell-based system
1. 
Cell-free protein production, with its high degree of customizability, is an interesting 
alternative to conventional  cell-based techniques.  The most common approach to cell-free 
protein expression has been solution phase systems (SPS), in which gene templates are put in 
solution with cell lysates containing the components required for transcription and translation.  
Yields with these systems, however, have not extended beyond the µg/ml range
2,3. 
   2 
 
Our group has recently developed the p-gel system, a DNA hydrogel made up of genes 
(linearized plasmids) and branched DNA crosslinkers (X-DNA) that synthesizes protein in the 
presence of a compatible lysate (Figure 1B)
4,5.  Through the use of compatible sticky ends, these 
components can be assembled into a gel through a standard ligation reaction (Figure 1A).  Unlike 
SPS, this system’s structure offers gene protection for longer production viability as well as a 
faster turnover rate of expression enzymes through high local gene concentration
5.  The result is 
a cell-free system with significantly higher yields in the mg/ml range.  Furthermore, the p-gel 
system has demonstrated the ability to generate a wide-spectrum of proteins, though post-
translational modification remains a challenge. 
 
Figure 1: Synthesis and operation of the p-gel.  X-DNA and linear plasmids are combined in a 
ligation reaction to create the p-gel (A).  In the presence of a compatible lysate and expression 
metabolites, protein synthesis occurs (B).
5 
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T7 RNA Polymerase 
With this system in its infancy, the potential exists to further increase expression levels.  
One approach that has shown promise is to replenish the expression enzymes and metabolites by 
exchanging the lysate
6.  However, with the high expense of lysates, the ability of the p-gel 
system to produce its own  expression enzymes is an intriguing possibility.  Thus, the 
incorporation of the T7 RNA polymerase (T7P) came into consideration. 
T7P, the chief transcription enzyme from bacteriophage  T7, is known for its robust 
activity and strict promoter specificity
7.  Furthermore, it consists of a single subunit and does not 
require post-translational modification, making T7P an ideal candidate for expression with the p-
gel system.   4 
 
CHAPTER 2 
Materials and Methods 
Vector Selection 
  In order to clone T7P into the p-gel system, it must first be incorporated into a carefully 
selected plasmid.  An appropriate candidate required four key characteristics: 1) compatibility 
with  Escheria coli  expression  enzymes, 2) inclusion of  the T7P  promoter  so that T7P can 
transcribe its own gene (a positive feedback loop), 3) a specific affinity tag along with a means 
for removal (i.e. cleavage site), 4) an antibiotic resistance gene for colony selection, and 5) the 
means to incorporate the T7P gene. 
  This led to the selection of the Roche RTS pIVEX2.4d plasmid cloning vector.  
According to Roche
8, this plasmid is designed for use with Roche’s RTS cell-free protein 
expression system, which includes prokaryotic cell lysate.  Furthermore, as shown in Figure 2, 
the plasmid includes a T7P promoter sequence, a factor Xa cleavable N-terminal His6-tag, an 
ampicillin resistance gene, and a multiple-cloning site. 
 
Figure 2: Plasmid map of the pIVEX2.4d vector. The features of this vector include a T7P 





  To produce a T7P sequence suitable for ligation with the plasmid, PCR primers were 
designed to incorporate suitable restriction sites based on the wild-type T7P sequence
9 
(Appendix A1).  Roche identifies NcoI and SmaI as the ideal candidates for use with 
pIVEX2.4d
8.  Accordingly, these restriction sites were placed on the primers to flank the gene 
and place it in the reading frame established by the T7P promoter included on pIVEX2.4d.  
Furthermore, the location of NcoI on pIVEX2.4d relative to the N-terminal His6-tag and Xa 
cleavage site required that the T7P start codon be included in the restriction site.  Unfortunately, 
the NcoI sequence includes a guanine base following this A-T-G start tag, which differs from the 
adenine included in the wild-type sequence for T7P.  This resulted in a minor missense mutation 
from asparagine to aspartic acid, which substitutes a carboxyl group for the relatively similar 
carboxamide functional group.  Furthermore, while the N-terminal domain does play a role in 
binding template DNA, the key amino acids are located further downstream
7, suggesting that this 
mutation wouldn’t significantly affect the activity of T7P. 
  Once the primer sequences were selected, they were tested for secondary structure 
formation resulting from self-complimentarity as well as nonspecific binding on the interior of 
the T7P sequence using Primer3 v. 0.4.0
10. 
 
Amplification of Gene of Interest 
  In order to amplify the T7P gene in anticipation of our cloning procedure, E. coli strain 
BL21 (DE3) was used as the genetic source.  As the genetic source did not contain the restriction 
enzyme sites to be used for ligation, a melting point (Tm) was calculated based on bases directly 
complementary to the genetic source
10.  However, this only accounts for a high efficiency first 6 
 
passage with the bacterial genome acting as the PCR template.  When the amplicon is available 
as the PCR template, the entire length of the primers is complementary and results in a higher 
Tm.  In order to compensate for this discrepancy, shorter primers (with a Tm similar to the one 
previously calculated) were included in the PCR reaction
10 (Appendix A2). 
  To amplify the gene, New England Biolabs Taq 5x Master Mix (N-DNAP) was used with 
a protocol based on the manufacturer’s recommendation.  However, due to the inclusion of 
multiple primer sets, yield optimization was performed with respect to the annealing temperature 
via gradient PCR (Figure 3).  The optimized PCR protocol for N-DNAP is detailed in Appendix 
B1. 
 
Figure 3: Optimization of the PCR annealing temperature as shown on an electrophoresis gel. A 
PCR program was written with a temperature gradient of 55°C to 65°C during the annealing step 
and samples were run in duplicate.  Afterwards, the yields were analyzed via gel electrophoresis 
and three representative annealing temperatures are shown here.  60°C provided the best yields 
and was chosen for our PCR protocol. 7 
 
Due to mutation concerns, this procedure was also done using Finnzymes Phusion High-
Fidelity DNA polymerase (HF-DNAP).  This polymerase boasts an error rate of 4.4 × 10
-7, 5 
times lower than that of the N-DNAP.  Annealing temperature optimization was done for this 
procedure as well and the final protocol can be found in Appendix B2.  For both N-DNAP and 
HF-DNAP, an 800 µl reaction was performed.  To purify our ~2.6 kb amplicon, the sample was 
run on a 1% agarose gel (containing 15% GelRed) for 100 mins at 80V before being excised at 
and extracted via the GenScript® 5M Gel Extraction Kit. 
  
Amplification of Vector 
  From a previous experiment, a highly stable  E. coli  clone  (Appendix C)  containing 
pIVEX2.4d was available.  Furthermore, the plasmid carried the gene for renilla luciferase, an 
approximately 1 kilobase insert.  As the gene was inserted using the same set of sticky ends as 
were intended for T7P in this experiment, a successful digestion would provide the desired 
vector for ligation with T7P.  To reanimate the frozen stock, scrapings were used to inoculate LB 
media (100 μg/ml) and incubated at 37°C on a 200 rpm shake platform overnight.  The plasmid 
was then purified through the GenScript® Quickclean 5M Miniprep Kit. 
 
Plasmid Preparation 
  After amplifying our vector and insert, digestion reactions were prepared.  New England 
Biolabs High-Fidelity NcoI and SmaI were chosen for the double digestion as they display high 
efficiency in the same buffer with minimal star activity across  a large temperature range.  
However, the optimal reaction temperatures were different, so the reaction was completed in two 
steps.  In separate 20µl reactions for the vector and the insert, both enzymes were included at a 8 
 
concentration of 10 U/µg of DNA substrate.  The reaction was then incubated for 5 hours at 
25°C followed by 5 hours at 37°C, the ideal reaction temperatures for SmaI and NcoI, 
respectively.  To purify our products, the digestion solutions were run on a 1% agarose gel 
(containing  15%  GelRed) for 100 mins at 80V before being excised and extracted via the 
GenScript® 5M Gel Extraction Kit as before (Figure 4). 
 
Figure 4: Double digestion of the pIVEX2.4d and T7 RNA polymerase as shown on an 
electrophoresis gel.  The DNA bands are consistent with the expected size of our vector (~3.5 
kb) and insert (~2.7 kb).  The lower band in the left lane is ~1 kb, the expected size of the insert 
(renilla luciferase) removed from the circular plasmid substrate. 
 
  In order to prepare our plasmid for transformation, several 10 µl ligation reactions were 
prepared with a spectrum of insert-to-vector molecular ratios ranging from 10:1 to 1:10.  In each 
case, a minimum of 100 ng of each DNA segment was incubated with 1U of Lucigen T4 ligase 9 
 
and buffer at 25°C for 2 hours.  The efficiency of the ligation reaction was determined through 
comparison to the control, a ligation reaction without the insert (Figure 5). 
 
Figure 5: Ligation efficiency compared to a control on an electrophoresis gel.  The control (L0) 
is a ligation with only the vector, while the test ligation reaction (L1) includes both the vector 
and insert.  The clear difference in bands between the two lanes demonstrates the efficiency of 
our ligation reaction.  The multiple bands in lane L0 (and their appearance in L1) suggest that 
vector dimers form readily and need to be eliminated through selection by colony PCR. 
 
Transformation 
  Invitrogen TOP10 chemically competent cells were chosen as the transformants.  Similar 
to E. coli strain DH10B, TOP10’s genotype (Appendix D) makes it highly stable with a low 
mutation rate.  DNA recombination is prevented by knocking out recA (recombinase), while the 
removal of endA (endonuclease) improves plasmid preparations by eliminating non-specific 
digestion by Endonuclease 1.  Furthermore, this strain doesn’t feature T7P in its genome (i.e. 
non-DE3), eliminating the risk of a false positive resulting from colony PCR. 10 
 
  To prepare for the transformation, T7 ligase was inactivated by incubating the ligation 
mixture at 70°C for 15 minutes  to improve transformation efficiency.  To cool the ligation 
mixture and thaw the frozen competent cells, both were placed on ice for 5 minutes.  Then, 5 µl 
of the ligation mixture was added to 50 µl of competent cells and incubated on ice for an 
additional 5 minutes.  To heat shock the cells, they were placed in a 42°C water bath for 30 
seconds before being returned to the ice for another 2 minutes.  Then, 50 µl of the transformation 
mixture was spread on LB agar plates containing ampicillin (100 µg/ml) and incubated at 37°C 
overnight to allow for colony growth (Figure 6). 
 
Figure 6: Transformed E. coli colonies.  After transforming TOP10 chemically competent cells, 
the transformation mixture was spread on an LB agar plate containing ampicillin (100 µg/ml) 
and incubated at 37°C overnight.  The colonies that developed are shown here. 
 




As our restriction enzymes produced palindromic sticky ends, the ligation reactions had 
the potential to produce dimers of either the vector or the insert.  As only the vector provides 
ampicillin resistance, antibiotic selection eliminated the possibility of a colony carrying an insert 
dimer.  However, antibiotic selection alone could not eliminate colonies carrying a vector dimer.  
Instead, colony PCR was required to select for colonies carrying the plasmid of interest. 
In order to produce genetically homogenous colonies, colonies were chosen from the 
transformation plates and streaked for isolation on new LB agar plates (100 µg/ml) as shown in 
Figure 7. 
 
Figure 7: Genetically homogenous colonies produced by streaking for isolation.  A colony was 
taken from the transformation plate and streaked on a new LB agar plate containing ampicillin 
(100 µg/ml) in a diffuse pattern to generate isolated colonies. The plate was then incubated at 
37°C overnight and the colonies that developed are shown here. 
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Through a procedure similar to that used to amplify our gene of interest (Appendix D), 
colony PCR reactions were performed and run on 1% agarose gel (containing 15% GelRed) for 
100 mins at 80V (Figure 8).  Colonies that produced a DNA band of the correct size (~2.7 kb) 
were used to inoculate 50 ml of inoculate LB media (100 μg/ml) and incubated at 37°C on a 200 
rpm shake platform overnight.  The plasmids were then purified through the GenScript® 5M Gel 
Extraction Kit as before. 
 
Figure 8: Colony PCR for isolated transformant colonies as shown on an electrophoresis gel.  
Given that pIVEX2.4d provides ampicillin resistance, transformants carrying vector dimers as 
well as those carrying the plasmid of interest would grow our LB agar plates containing 
ampicillin (100 µg/ml).  The appearance of a ~2.6 kb band indicates the presence of our gene of 
interest, implying the corresponding colony carries the plasmid of interest. 
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 Sequencing 
  In order to check the integrity of our gene of interest, plasmid samples were submitted to 
the Cornell University Life Sciences Core Laboratories Center for sequencing with the Applied 
Biosystems Automated 3730 DNA Analyzer.  With a confidence interval of 50-500 bp following 
a sequencing primer, 6 primers were required to accurately sequence the entire T7P gene (Figure 
9).  In accordance with the Biotechnology Resource Center DNA Sequencing Handbook, primers 
were designed to be 17-25 nucleotides long and have a Tm of 55-65°C.  Once the primer 
sequences were selected, they were tested for secondary structure formation resulting from self-
complimentarity as well as nonspecific binding to our plasmid
10. 
 
Figure 9: Map of the plasmid of interest with 6 sequencing primers.  The primers were spaced to 
assure that the entire length of the gene of interest would be sequenced within the confidence 
interval of the Applied Biosystems Automated 3730 DNA Analyzer.  The locations of the 
restriction sites used to insert the T7 RNA polymerase gene as well as the primers melting 
temperatures are displayed in the figure. 
 
  Once the DNA Analyzer results were available, they were assembled into a consensus 
sequence and checked against the T7P  sequence as described in the literature
9.14 
 
   
CHAPTER 3 
Results and Discussion 
Mutations 
  Both the N-DNAP and HF-DNAP techniques generated multiple colonies containing our 
gene of interest.  However, upon sequencing it was found that none of the samples displayed 
complete  homogeneity to the published sequence, displaying  multiple mutations in each 
submitted sample.  The most common error was a point mutation that changed a single 
nucleotide (i.e. adenine substituting for guanine).  In a few cases, these mutations were silent due 
to a synonymous substitution that wouldn’t alter the amino acid sequence.  More commonly 
however, a missense mutation would occur, changing the codon to code for a different amino 
acid.  The ramifications of these mutations are difficult to anticipate, but may impact the 
expression or activity of T7P.  In the case of a nonsense mutation, the nucleotide substitution 
resulted in a stop codon, which would trigger  the early termination of the peptide during 
translation, most likely rendering the protein useless. 
Another family of mutations that appeared in our results was frameshift mutations: the 
addition or subtraction of a single nucleotide, shifting all of the downstream codons out of the 
proper reading frame.  Consequently, the amino acid sequence following the mutation site is 
completely altered, resulting in a distinctly different peptide. 
 
Source of Mutation 
  There are a number of different areas of our procedure that could have contributed to the 
high mutation rate seen in our final product.  The first to consider is the genetic source, 15 
 
BL21(DE3).  As our genetic source was an isolated BL21(DE3) colony, genetic homogeneity 
among genomes is assumed.  Thus, if mutations were present in this genetically homogenous 
population, we would expect our clones to exhibit at least some of the same mutations.  Instead, 
mutation locations and types were highly varied, making the bacterial genome an unlikely source 
of the problem. 
The amplification of our insert via PCR is another potential source of mutation.  While 
the use of HF-DNAP produced fewer mutation sites per sample than N-DNAP (2.4 ± 1.0 versus 
7.2 ± 2.9) over a very small sample size, it seems very unlikely that this degree of mutation is 
due to PCR alone.  With the 4.4 × 10
-7 error rate of the Finnzymes DNA polymerase, a 2.7 kb 
amplicon should encounter an error every 875 duplications, approximately.  This would generate 
an overwhelmingly homogenous mutation-free population, though a few mutants are likely.  The 
fact that all of our samples showed multiple mutations without exception suggests there are other 
factors to consider. 
Our competent cells could also generate mutations during their multiplication.  However, 
the TOP10 genotype is consistent with industry standards for stable cloning and expression, 
making this an unlikely source of mutation as well.   16 
 
CHAPTER 4 
Conclusions and Outlook 
 
  Without a clear indication of the mutation source, the issue deserves further investigation.  
One way to accomplish this would be to sequence the insert at each stage of the procedure – 
namely the genetic source and amplified gene of interest.  Nonetheless, with additional work, our 
results could be useful in p-gel expression studies. 
 
Viability Testing 
While all of our samples did have several mutations, a few candidates avoided major 
mutations (i.e. nonsense and frameshift mutations).  It’s plausible that candidates with few 
missense mutations could preserve their activity nonetheless, but viability tests would be 
necessary to draw this conclusion.  As the pIVEX2.4d vector is intended for use with Roche’s 
cell-free RTS E. coli  system, this solution phase system could be used to produce the T7P 
mutant.  As this expression system uses T7P in its transcriptional process, we would need to 
separate the expressed product from that introduced in the lysate.  Fortunately, the N-terminal 
His6-tag would allow for the affinity purification of our product and could be removed via factor 
Xa cleavage.  Once purified, and with a compatible DNA template (e.g. the plasmid produced 
above), the activity levels of our T7P mutant could be determined through quantitative real-time 
reverse-transcription PCR and comparison to a control. 
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Site-directed Mutagenesis 
  Alternatively, a mutation-free plasmid could be generated through site-directed 
mutagenesis.  By using the wild-type sequence at the location of the mutation as a primer, PCR 
would generate a new plasmid with the mutation corrected.  While the generated plasmid will 
contain a nick, this is be corrected by the competent cell (albeit with a lower transformation 
efficiency).
11   
 
Predictions 
  While cloning T7 RNA polymerase into the p-gel is an exciting prospect in terms of 
increasing its autonomy, expressing other transcriptional and translational machinery requires 
significant post-translational modification, which, to date, has not been demonstrated in the p-
gel. 
Beyond the incorporation of expression enzymes into the p-gel, the various extensions of 
this project hold the potential to make significant strides in synthetic biology.  Oscillatory 
networks of transcriptional regulators, such as the repressilator, have been constructed within 
living cells, however the abundance of interferences posed by the cells’ intrinsic activity result in 
a high-degree of noise
12.  With the relatively simple framework of the p-gel, these interferences 
would be significantly reduced.  As the body of work concerning the expression kinetics of the 
p-gel increase, designing finely-tuned biological circuits is a distinct possibility. 
   18 
 
APPENDIX 
Appendix A: PCR Primers 
A1: “Long” primers 
 
The inclusion of the NcoI restriction site (green) and SmaI restriction site (red) 
are shown above.  While the melting temperatures  of the two primers are distinctly 
different, only the complementary region needs to be considered.  The relevant melting 
temperatures are shown above in parentheses.  Also, note the missense mutation induced 
by the use of the NcoI site, coding for aspartic acid instead of asparagine. 
 A2: “Short” primers 
 19 
 
As the shorter primers were designed with consideration to the amplicons, the 
entire length of these primers were considered in melting temperature calculation. 
   20 
 
Appendix B: PCR Protocols 
  B1: New England Biolabs Taq 5x Master Mix 
    Reagents 
Component  Concentration 
Long Forward Primer  0.2 µM 
Short Forward Primer  0.5 µM 
Long Reverse Primer  0.2 µM 
Short Reverse Primer  0.5 µM 
Taq 5x Master Mix  1x 
E. coli strain BL21(DE3)  0.1 µl per 50 µl reaction 
Nuclease-free water  Quantum suffice 
 
    Protocol 
Phase  Temperature  Time 
Initial denaturation  95°C  5 min 
Denaturation  95°C  1 min 
Annealing  60°C  30 sec 
Extension  72°C  2 min 
Final Extension  72°C  5 min 
 
B2: Finnzymes Phusion High-Fidelity DNA Polymerase 
    Reagents 
Component  Concentration 
Long Forward Primer  0.2 µM 
Short Forward Primer  0.5 µM 
Long Reverse Primer  0.2 µM 
Short Reverse Primer  0.5 µM 
5x Phusion® HF Buffer  1x 
dATP  200 µM 
dTTP  200 µM 
dGTP  200 µM 
dCTP  200 µM 
E. coli strain BL21(DE3)  0.1 µl per 50 µl reaction 
Nuclease-free water  Quantum suffice 
 
30 cycles 21 
 
    Protocol 
Phase  Temperature  Time 
Initial denaturation  98°C  5 min 
Denaturation  98°C  30 sec 
Annealing  64°C  30 sec 
Extension  72°C  2 min 
Final Extension  72°C  5 min 
 
   
20 cycles 22 
 
Appendix C: E. coli Strain TOP10 Genotype 
F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara leu) 
7697 galU galK rpsL (Str
R) endA1 nupG 
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Appendix D: Colony PCR Protocol 
    Reagents 
Component  Concentration 
Short Forward Primer  0.2 µM 
Short Reverse Primer  0.2 µM 
Taq 5x Master Mix  1x 
Transformant colony  0.1 µl per 50 µl reaction 
Nuclease-free water  Quantum suffice 
 
    Protocol 
Phase  Temperature  Time 
Initial denaturation  95°C  5 min 
Denaturation  95°C  1 min 
Annealing  60°C  30 sec 
Extension  72°C  2 min 
Final Extension  72°C  5 min 
 
 
   
30 cycles 24 
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